As of April 19, 2025, Oramed Pharmaceuticals (ORMP) has a market cap of $87.829 million USD. According to our data, Oramed Pharmaceuticals is ranked No.7688 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $87.83 M |
-9.97%
|
Dec 31, 2024 | $97.56 M |
4.76%
|
Dec 29, 2023 | $93.12 M |
-80.80%
|
Dec 30, 2022 | $0.48 B |
-15.76%
|
Dec 31, 2021 | $0.58 B |
236.79%
|
Dec 31, 2020 | $0.17 B |
-17.67%
|
Dec 31, 2019 | $0.21 B |
71.67%
|
Dec 31, 2018 | $0.12 B |
-66.67%
|
Dec 29, 2017 | $0.36 B |
47.06%
|
Dec 30, 2016 | $0.25 B |
-28.42%
|
Dec 31, 2015 | $0.34 B |
87.50%
|
Dec 31, 2014 | $0.18 B |
-70.45%
|
Dec 31, 2013 | $0.62 B |
289.65%
|
Dec 31, 2012 | $0.16 B |
17.86%
|
Dec 30, 2011 | $0.14 B |
-6.67%
|
Dec 31, 2010 | $0.15 B |
-33.33%
|
Dec 31, 2009 | $0.22 B |
15.38%
|
Dec 31, 2008 | $0.19 B |
50.00%
|
Dec 31, 2007 | $0.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novo Nordisk
NVO
|
$285.37 B |
89.978 B
|
![]() Denmark
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
![]() Israel
|
Market Cap | = | ORMP Stock Price | * | ORMP Shares Outstanding |
= | $2.15 | * | 40.85 M | |
= | $87.83 M |